![Jong-Gil Shin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 4 M $ op 31-05-2026
Jong-Gil Shin is currently the Chief Financial Officer, Director & Senior MD at Onconic Therapeutics, Inc. He holds an MBA from Tuck School of Business at Dartmouth.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-04-2026 | 329.365 ( 0,73% ) | 4 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCONIC THERAPEUTICS INC. | Financieel Directeur/CFO | 01-01-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onconic Therapeutics Co., Ltd.
 Onconic Therapeutics Co., Ltd. BiotechnologyHealth Technology Operates as a drug discovery and development company which develops therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
